Page last updated: 2024-11-04

sulfanilamide and Psoriasis

sulfanilamide has been researched along with Psoriasis in 2 studies

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
OFUJI, S1
TACHIBANA, K1
ODA, S1
EL-NASR, HS1
EL-HEFNAWI, H1

Other Studies

2 other studies available for sulfanilamide and Psoriasis

ArticleYear
[OBSERVATIONS ON PUSTULOSIS PALMARIS ET PLANTARIS. EXTRA-PALMO-PLANTAR LESIONS AND THERAPEUTIC EFFECTS BY REMOVAL OF INFECTIVE FOCI].
    Hifuka kiyo. Acta dermatologica, 1963, Volume: 58

    Topics: Erythema Nodosum; Erythromycin; Humans; Psoriasis; Pyoderma; Staphylococcus; Sulfanilamide; Sulfanil

1963
ACRODERMATITIS CONTINUA OF HALLOPEAU.
    The Journal of the Egyptian Medical Association, 1963, Volume: 46

    Topics: Acrodermatitis; Anti-Bacterial Agents; Diagnosis, Differential; Drug Therapy; Egypt; Finger Injuries

1963